-
Synthetic Biotech Research Microbe Developed
An artificial form of marine bacteria is being created to speed experiments in biotechnology labs on cloning and design of new therapeutic proteins.
-
Heart Research Built Into Personalized Activity Tracker
An activity tracking device introduced earlier this year uses data from a major population health study to write its algorithms measuring exercise achievement to prevent heart disease.
-
Spacecraft Returns with Space Station Research Samples
A SpaceX Dragon spacecraft returned today with samples from several biomedical research studies conducted by astronauts on the International Space Station.
-
Small Business Award Funding Epilepsy Drug Research
A federal grant is funding a project by Neuroene Therapeutics, a start-up enterprise in South Carolina to develop a new class of drugs to treat epilepsy.
-
Inexpensive Hydrogen Storage Devised for Solar Energy
An engineering team in Switzerland designed a system for producing hydrogen from solar power with abundant available materials, providing an inexpensive and feasible energy storage method.
-
Lower-Risk Blood Thinning Drugs Designed
Researchers from academic and industry labs designed anti-coagulation treatments for people in danger of blood clots, but less likely to cause excessive bleeding than current drugs.
-
Patent Set for Heart Tissue Regeneration Drug
A drug developed by MDI Biological Laboratory that stimulates growth of heart tissue to fix damage from heart attacks is scheduled to receive a U.S. patent.
-
So Many Lights To Choose From But Which One Shines The Brightest, A Guide To LEDs
Everyone should make a conscious effort to help the environment and switching to LEDs is just one simple way.
-
University Spin-Off Developing Sepsis Drug
A spin-off enterprise from University of British Columbia is licensing a cholesterol-lowering drug from drug maker Novartis to develop a treatment for sepsis and other severe infections.
-
Stem Cells, Engineered Protein Reverse Stroke Damage
A combination of stem cells and synthetic human protein was shown in lab mice to repair damaged brain cells a week after an induced stroke.